NeoBiocon to sell anti-diabetic drug in UAE
Vildagliptin is available as monotherapy and in combination with metformin. Both the drugs commands over 30 percent of the DPP-IV market in the UAE.
Dec 10, 2015, 20:47 PM IST
Antim Baazi: NeoBiocon Partners with Novartis
NeoBiocon Partners with Novartis which shows good momentum in Biocon intra-day trading.
Dec 09, 2015, 19:38 PM IST
Biocon Q2 net profit jumps 3-fold at Rs 306 crore
Biotechnology major Biocon Tuesday reported an over two-fold jump in its consolidated net profit at Rs 306 crore for the second quarter ended September 30, 2015.
Oct 20, 2015, 23:22 PM IST
Investors reposed faith in our future growth prospects: Syngene
Readying to list its shares after a bumper 32-times over-subscribed IPO, biotechnology major Biocon's research arm Syngene on Thursday said the investors have reposed faith in its future growth prospects.
Jul 30, 2015, 16:51 PM IST
SEBI's insider trading norms 'draconian': Biocon's Shaw
In a sharp criticism of regulator SEBI's new insider trading norms, industry leader and Biocon chief Kiran Mazumdar Shaw Friday said these rules have "draconian intent" and will kill the ESOPs.
Jul 24, 2015, 22:47 PM IST
Biocon sets price band at Rs 240-250 for research arm's IPO
Biotechnology major Biocon Ltd has set the price band at Rs 240-250 per equity share for the initial public offering of its research arm Syngene International Ltd.
Jul 16, 2015, 09:10 AM IST
Syngene gets nod to raise foreign investment to 44%
Syngene, a subsidiary of Biocon, on Monday said it has received the Foreign Investment Promotion Board (FIPB) approval for raising foreign investment in the company to 44 percent from the earlier approved 10 percent.
Jun 22, 2015, 15:27 PM IST
Govt approves FDI worth Rs 4,000 cr in pharma sector
Proposals for foreign direct investment amounting to around Rs 4,000 crore by four pharma and medical devices firms, including Torrent Pharmaceuticals and Biocon's research services arm Syngene, were on Wednesday approved by the government.
Jun 17, 2015, 17:15 PM IST
Biocon's arm Syngene gets SEBI nod for IPO
Syngene International, research arm of biotechnology major Biocon, has received capital markets regulator SEBI's approval to launch an initial public offer (IPO).
Jun 15, 2015, 20:15 PM IST
Biocon, Mylan drug discovery programme makes progress
Biocon shares were trading at Rs 425.90 apiece, up 0.16%, on the BSE.
May 07, 2015, 14:01 PM IST
Biocon Q4 consolidated net surges 78%
During the quarter, Biocon reported exceptional gain of Rs 105.06 crore on account of share sale in its research services subsidiary Syngene.
Apr 30, 2015, 11:31 AM IST
Biocon files IPO prospectus for R&D arm Syngene
Biotech firm Biocon Ltd has filed a prospectus for the initial public offering of its USD 600 million research and development arm, Syngene, it said on Thursday.
Apr 23, 2015, 10:07 AM IST
Biocon files prospectus for Syngene IPO to raise Rs 600 cr
Biotechnology major Biocon Wednesday filed prospectus with market regulator SEBI for the initial public offer of its research arm Syngene through which aims to raise around Rs 600 crore that will be used to fund its R&D programmes.
Apr 22, 2015, 20:00 PM IST
Biocon arm Syngene appoints Peter Bains as CEO
Biotechnology major Biocon's custom research arm Syngene has appointed Peter Bains as its Chief executive Officer (CEO).
Apr 01, 2015, 18:09 PM IST
Biocon arm to have 40-acre new plant in Mangalore SEZ
Biocon's research services arm Syngene International would set up a new plant at Mangalore SEZ to manufacture pharma ingredients and agro chemicals.
Mar 31, 2015, 20:33 PM IST
Mazumdar-Shaw honoured by Federation University Australia
Biocon Chairperson Kiran Mazumdar-Shaw has been honoured by Federation University Australia (FedUni) by dedicating a road at the University's Mt Helen Campus and naming it as 'Mazumdar Drive.'
Mar 05, 2015, 21:09 PM IST
Biocon to invest 10% of biopharma revenues on R&D next fiscal
Continuing it emphasis on innovation, biotechnology major Biocon plans to spend 10 percent of its annual biopharma revenue on research and development in the next fiscal year.
Feb 01, 2015, 20:27 PM IST
Biocon completes 10% stake sale in Syngene
Biotechnology major Biocon on Monday concluded sale of 10 percent stake in its research arm Syngene for Rs 380 crore to IVF Trustee Company Private Ltd.
Jan 12, 2015, 19:26 PM IST
'Biocon planning to set up manufacturing unit in Vizag'
Pharmaceutical giant Biocon is contemplating setting up a manufacturing facility in Visakhapatnam, Andhra Pradesh government said Sunday.
Dec 14, 2014, 18:34 PM IST
Biocon Q2 Net flat at Rs 102 crore
Biotechnology major Biocon on Wednesday reported a flat growth in its consolidated net profit at Rs 102.05 crore for the quarter ended September 30, 2014.
Oct 22, 2014, 13:36 PM IST
